Locus control regions (LCRs) 
Introduction
The use of replicating episomal vectors (REVs) 1 offers an attractive alternative to integrating retroviral and adenoassociated viral (AAV) vectors for producing long-term gene expression within a gene therapy context. First, REVs do not pose the same size limitations on the therapeutic transcription unit as do viral vectors, with inserts in excess of 300 kb being a possibility. 2 Second, being episomal, REVs do not suffer from potential hazards associated with insertional mutagenesis that is an inherent problem with integrating viral vectors. Lastly, REVs are introduced into the target cells using nonviral delivery systems that can be produced more cheaply at scale than with viral vectors. [3] [4] [5] REVs based on viral origins of replication such as those from EBV, 6 human papovavirus BK, 7, 8 mammalian chromosomal origins of replication have also been found to improve nuclear retention of the episomes. 11, 12 It has been demonstrated that both non-replicating, transiently transfected plasmids, 13, 14 as well as REVs, 13, 15, 16 assemble nucleosomes. Assembly on REVs is more organised and resembles native chromatin, whereas nucleosomes on transient plasmids are less well ordered allowing greater access of transcription factors to target sequences. 14 These observations imply that transcriptional control elements with a potent chromatin remodelling capacity may be required for efficient longterm tissue-specific gene expression from within REVs. One such class of elements are locus control regions (LCRs). 17 LCRs are tissue-specific regulatory elements which are able to overcome chromatin position effects and confer upon a gene linked in cis, site-of-integration, physiological levels of expression directly proportional to transgene copy number in mice. 18 LCRs are able to obstruct the spread of heterochromatin and prevent position effect variegation (PEV) . 19 This pattern of expression conferred by LCRs suggests that these elements possess a powerful chromatin remodelling capability and are able to establish and maintain a transcriptionally competent, open chromatin domain. Therefore, LCRs are seen as the most efficient means of achieving reproducible, physiological levels of gene expression from stably integrated transgenes.
Gene Therapy
The requirements for tight tissue-specific gene expression from within REVs, at a sustained level to be of long-term therapeutic benefit, has to date been poorly addressed. We have therefore assessed the ability of LCRs to drive efficient, tissue-specific gene expression from within REVs using the human ␤-globin LCR (␤LCR) as a model system. The ␤LCR consists of five elements spread over 16 kb of DNA located 5Ј of the entire ␤-globin gene family and which are characterised by high sensitivity to digestion with DNaseI. 17 Components of the ␤LCR have been incorporated into both retroviral and AAV vectors. 20 The ␤LCR is seen as an essential part of transcription units to reproducibly generate sufficiently high levels of ␤-globin to be of value in the gene therapy for the haemoglobinopathies. 20, 21 In this study, we have assessed the expression of the human ␤-globin gene either alone or in combination with elements of the ␤LCR within plasmid REVs and show that long-term, high levels of erythroid-specific expression can be conferred by this element. In addition, a 38-kb ␤LCR minilocus cosmid REV is efficiently propagated in an episomal state and retains high levels of ␤-globin gene expression. This demonstrates the potential utility of this system for gene therapy applications.
Results

Plasmid episomal replication and copy number of LCR/␤-globin gene constructs in K562 and HeLa cells
The ␤-globin gene either alone or in combination with one or more of the three transcriptionally most potent DNaseI hypersensitive (HS) sites (HS2, 3 and 4) that constitute the ␤LCR 17 were inserted into the EBV-based plasmid vector p220.2 ( Figure 1 ). 6 These constructs were then used to generate stable transfected pools of the human myelogenous leukaemia cell line K562. These cells constitutively express the embryonic -and foetal ␥-globin, but not the adult ␤-globin genes. 22 However, it has been shown that a stably integrated human ␤-globin transgene under control of the ␤LCR linked in cis, is unlike the endogenous ␤-globin genes, efficiently expressed in K562 cells. 23 Current models suggest that this is due to the absence of a ␥-globin gene on the transgene construct that would otherwise compete for the ␤LCR and be preferentially transcribed. 17 This allows the ␤-globin reporter on the REVs to be quantified without interference from the homologous endogenous genes. In addition, four key constructs (␤, 2␤, 3␤ and 432␤) were introduced into human HeLa cells, which acted as a non-erythroid control.
The episomal status of the ␤LCR/␤-globin gene plasmid constructs was determined as follows. Total DNA from the transfected pools of K562 cells was digested with BamHI and HindIII and Southern blotted. These restriction enzymes liberate the p220.2 vector backbone as an 8.9 kb fragment (Figure 1a ) only if the constructs remain as independent episomes. These blots were probed using the plasmid pBluescript that possesses extensive homology to the pBR322 region of p220.2. The results (Figure 1b) , show a single band corresponding to the size of linearised p220.2 indicating that within K562 cells, the ␤LCR/␤-globin gene episomal constructs were present only as non-integrated episomal DNA. Similar results were obtained for constructs transfected into HeLa cells (data not shown). One of the pools harbouring the ␤LCR HS3-␤ globin gene construct (3␤) was used as a representative sample to confirm the presence of episomal plasmid DNA by fluorescence in situ hybridisation (FISH) analysis of metaphase spreads. Figure 1c shows a typical example of 10 microscopic fields that were studied. As K562 cells are trisomy 11, 22 the results clearly showed three pairs of signals corresponding to the ␤-globin loci on these chromosomes (Figure 1c, arrowheads) . No other pairs of signals associated with sister chromatids were detected indicating the absence of integrated copies of the transfected 3␤ construct. However, a number of single focal signals were observed consistent with the presence of episomal copies of 3␤.
In order to determine if the ␤LCR/␤-globin/REV plasmid constructs replicated extrachromosomally in K562 and HeLa cells, a low molecular weight DNA fraction was prepared, 24 digested with DpnI and retransformed into E. coli. Since human cells lack DNA adenine methylase activity, replicated REV DNA is insensitive to digestion with DpnI. This allows prokaryotic, input plasmid DNA to be differentiated from that which has undergone replication within either K562 or HeLa cells. Restriction enzyme analysis of plasmid DNA prepared from between five and 10 colonies obtained with DNA rescued from transfected K562 or HeLa cells was found to be identical to the original input plasmid DNA used in the transfection, indicating that these plasmid molecules had replicated without detectable rearrangements within the human cells (data not shown).
The average copy number of the ␤LCR/␤-globin gene episomal constructs in both K562 and HeLa cells, was estimated by Southern blot analysis of EcoRI-digested, total DNA from stably transfected pools and probed with a 920-bp fragment spanning IVS-II of the human ␤-globin gene (see Materials and methods; data not shown). The K562 pools had a copy number between 3 and 5 except for the ␤LCR HS3 construct containing cells that showed an average copy number of 10 ( Figure 2b ). The stably transfected HeLa cell pools had an average copy number of 1-2, except for the ␤LCR HS3 (3␤) construct which contained on average five copies (Figure 2c ).
Expression of LCR/␤-globin gene REV plasmid constructs in erythroid and non-erythroid cells
Expression of the ␤LCR/␤-globin gene/REV constructs in erythroid K562 cells was assessed using an S1-nuclease protection assay employing end-labelled DNA probes. 25 Total RNA isolated from stable transfected K562 cells was simultaneously probed for ␤-globin transgene and endogenous ␥-globin mRNA. The ␤-globin gene signals were quantified and normalised using the endogenous ␥-globin mRNA signal as an internal reference (see Materials and methods).
The ␤-globin gene alone gave very low levels of expression that were barely detectable in our assay ( Figure  2b ) giving a maximum of 13.6% of endogenous ␥-globin mRNA levels per episome copy.
In order to determine whether the ␤LCR HS sites maintain their ability to drive strict erythroid-specific gene expression from within an REV context, a number of key constructs were analysed in non-erythroid HeLa cells. Expression of the human ␤-globin gene was determined by the same S1-nuclease protection assay that was used to analyse the transfected K562 cells. The ubiquitously expressed hnRNPA2 mRNA was used as internal reference to normalise the ␤-globin signal (see Materials and methods).
Although a signal of human ␤-globin mRNA could be detected from cells transfected with the ␤-globin gene alone, the addition of HS2, HS3 or the HS234 combination, failed to enhance expression ( Figure 2c ). These data demonstrate that the ␤LCR confers tissue-specific expression from within REVs.
Maintenance of episomal status and gene expression
In order to test the maintenance and stability of gene expression of the ␤LCR/␤-globin/REVs within K562 cells as a function of time, stable transfected pools containing the ␤-globin gene with ␤LCR HS2, HS3 and the HS234 combination were cultured continuously for 30 days in the absence, as well as presence of hygromycin drugselective pressure. Southern blot analysis was used as before ( Figure 1b) to assess episome copy number over the 30-day period of culture. The results showed that in the presence of hygromycin there was no significant drop of episomal copy number, whereas in the absence of selection there was a gradual decrease (data not shown). However, this rate of episomal loss varied between pools and appeared to largely depend upon the copy number at the initial stages of the transfection before removal of hygromycin from the culture medium. In some cases there was almost complete loss of episomes (Ͻ1 copy per cell) by day 30 (data not shown).
Since the rate of episome loss was different for each pool, ␤-globin gene expression was determined at the point where 50% of the episomes were lost from the cultures. In the absence of hygromycin, the 432␤ construct maintained ␤-globin gene expression per copy at a similar (80-100%) level to that observed before commencement of the 30-day period of culture in the absence of the drug (Figure 3a , ϪHygromycin; 432␤ columns). However, the 2␤ or 3␤ episomes both showed a significant decline in ␤-globin gene expression after hygromycin was removed (Figure 3a , ϪHygromycin). The pools with the 2␤ construct gave 10-20% of the original value of ␤-globin gene expression per episome copy, whilst the 3␤ construct showed only 4-6%. Surprisingly, similar results were obtained with the parallel cultures growing in the presence of hygromycin (Figure 3a, +Hygromycin) . Despite no obvious drop in episomal copy number, ␤-globin gene expression markedly decreased over 30 days of culture in the pools harbouring either 2␤ (41-59%) or 3␤ (6.5%) when compared with the level seen on day 1 (Figure 3a , +Hygromycin; columns 2␤ and 3␤). In con- trast, 432␤ maintained ␤-globin gene expression at the same level throughout the 30-day culture period (Figure  3a , +Hygromycin; columns 432␤). FISH analysis confirmed that this resulted from episomal, rather than integrated copies of the 432␤ construct (Figure 3b ).
General DNaseI sensitivity of 432␤ and 3␤
The silencing of transgene expression in K562 cells containing human ␤-globin under ␤LCR HS3 control (3b; Figure 3a ), suggests changes in the chromatin structure of these REV molecules 13, 15, 16 to a transcriptionally nonpermissive state. We therefore determined the general DNaseI sensitivity of the 3␤ REV episomes in K562 cells after 30 days of continuous culture in the presence of drug-selective pressure, during which time ␤-globin gene expression is silenced, and compared this with cells containing the ␤LCR HS234-driven construct (432␤), where gene expression is retained over the same period ( Figure  3a ). Nuclei were prepared from these transfected pools of cells and digested with limiting amounts of DNaseI. Total DNA from these nuclei was then digested with XbaI and after gel electrophoresis and Southern blotting, was hybridised with a probe consisting of a genomic fragment spanning the second intron of the human ␤-globin gene. This probe detects an 11-kb fragment from the endogenous ␤-globin locus, a 4.5-kb band from 432␤ and 6-kb band from the 3␤ REV episomes (Figure 4a and b) . The intensities of these signals were then quantified by PhosphorImager. Since endogenous ␤-globin does not express in K562 cells, the chromatin structure around this gene within the native locus should remain similarly accessible to DNaseI digestion over the 30-day period of culture. Therefore, the ratio of the intensities of the endogenous ␤-globin band with respect to that of the episome-derived band was used as a measure of the latter's rate of disappearance and hence overall sensitivity to DNaseI digestion (see Materials and methods). If DNaseI digests the endogenous and episome-derived ␤-globin fragments at a similar rate before and after the 30-day period of continuous culture, their ratio over the DNaseI digestion series will remain similar at these two time-points. However, if the episomal chromatin structure becomes more resistant to DNaseI digestion, the ratio between the two bands will be altered. As shown in Figure 4c , in the case of 432␤, the trend in the ratios over the DNaseI digestion series before and after 30 days of culture, are similar suggesting that there is no obvious change in the general DNaseI sensitivity of the plasmid REV chromatin. However, in the case of 3␤ (Figure 4d) , the ␤-globin gene becomes more resistant to DNaseI digestion after 30 days as demonstrated by an increasing endogenous to episomal ␤-globin gene ratio indicating the formation of a less DNaseI-sensitive structure. Similar results were obtained from two independently transfected pools.
High-level gene expression from ␤LCR minilocus REVs
The results obtained with the p220.2 plasmid-based REVs (Figure 2) show increasing efficiency of gene expression as the ␤LCR employed becomes more complete. We therefore decided to test the efficacy of the minilocus ␤LCR 26 within a REV context. The principal features of this 38-kb construct are a 21-kb genomic region spanning the complete ␤LCR region linked to a 4.98-kb ␤-globin gene fragment with approximately 1.5-kb 5Ј and 1.8-kb 3Ј flanking sequences. This ␤-globin minilocus was incorporated into the cos203 REV cosmid vector (cos203␤; see Materials and methods) and analysed in both the foetal/embryonic and adult stage erythroid environments of K562 and murine erythroleukaemia (MEL) cells, respectively. Analysis of total genomic DNA from two independently generated pools of stable transfected cells Gene Therapy Figure 4 The 3␤, but not the 432␤, plasmid REV becomes less sensitive to DNaseI digestion in K562 cells over a prolonged (30- 
.5 kb in length. Lanes 0, no DNaseI control. (b) DNaseI sensitivity of 3␤. The episomal (Epi) ␤-globin transgene is a 6-kb fragment. Lanes 0, no DNaseI control. (c) Relative DNaseI sensitivity of 432b REVs. The Endo/Epi signal ratios from panel (a) were calculated to give the relative DNaseI sensitivity after comparison with the no-DNaseI control (lanes 0; see text and Materials and methods). This reflects the trend of DNaseI sensitivity over the digestion series at day 0 (᭜) and day 30 (̆). (d) Relative DNaseI sensitivity of 3␤ REVs. The Endo/Epi signal ratios from panel (b) were calculated as in (c) above. Day 0, ; day 30,̆. Note increased resistance to DNaseI digestion of the day 30 sample.
of both types by digestion with SalI followed by pulsedfield gel electrophoresis and Southern blot hybridisation, showed the presence of the 38-kb ␤-globin minilocus construct, as well as the cos203 cosmid vector backbone in both K562 (Figure 5a, lanes 1 and 2) and MEL (Figure 5a , lanes 3 and 4) cells confirming the presence of episomes 3-4 weeks after transfection and drug selection. Further Southern blot analysis of genomic DNA digested with EcoRI and DpnI, showed that replication of episomes had occurred and were present at an average copy number of 1-2 per cell in K562 (Figure 5b, lanes 1 and 2) and one copy per cell in MEL (Figure 5b, lanes 3 and 4) pools. The ability of the cos203␤ cosmid vector to establish episomal status in MEL cells is in marked contrast to the p220.2
Gene Therapy plasmid-based constructs (Figure 1 ), which were unable to do so (data not shown).
Episomal transgene expression from cos203␤ as assessed by S1-nuclease protection (see Figure 2) , showed that in K562 cells (Figure 6a , lanes 1 and 2) expression per episomal copy was 25-30% of endogenous ␥-globin levels (Figure 6b, K562) . Expression in MEL-transfected pools (Figure 6a, lanes 3 and 4) was similar to that seen in K562 cells at between 20 and 38% of the endogenous ␤ maj -globin per episome copy (Figure 6c, MEL) . These results show that cos203␤ gives comparable expression in both an embryonic/foetal (K562) and adult (MEL) cell environment at a level that would be of therapeutic value if reproduced in vivo.
Figure 5 Episomal replication of cos203␤ cosmid REV within both embryonic/foetal human K562 and murine adult MEL erythroid cells. Pools of embryonic/foetal K562 and adult MEL erythroid cells stably transfected with the cos203␤ cosmid REV analysed for episomal integrity and transgene copy number. (a) Total genomic DNA from two independently generated, cos203␤ transfected pools of K562 (lanes 1 and 2) and MEL (lanes 3 and 4) cells was digested with SalI, resolved by pulsed-field gel electrophoresis and Southern blotted. The blots were then double probed with a 3.6-kb fragment encompassing the human ␤-globin gene and the cos203 vector backbone. Lane Ck, untransfected K562 cells; lane Cm, untransfected MEL cells as negative controls. The bands corresponding to the 38 kb ␤-globin minilocus and the 9 kb cos203 vector are indicated by arrowheads on the right. M(kb), positions of size markers in kb. (b) Total DNA from the same pools of K562 and MEL cells as in panel (a) above analysed for cos203␤ copy number by digestion with EcoRI and DpnI and Southern blot hybridisation. The samples from K562 cells were hybridised with the BamHI-EcoRI ␤-globin intron II probe, giving a 5.5 kb endogenous band (h␤) and a 4.3 kb cos203␤ derived band (cos203␤). MEL cell samples were double-probed for the endogenous murine vav gene, which detects a 6.5-kb fragment (mvav), as well as with ␤-globin intron II. Human ␤-globin gene-containing plasmid DNA was used as a positive control (lane C, pl). M(kb), positions of size markers in kb.
Figure 6 The cos203␤ REV gives expression in both embryonic/foetal K562 and adult MEL erythroid cell types and is efficiently retained in K562 cells without drug selective pressure. Total RNA from two independently generated pools of K562 and MEL cells stably transfected with cos203␤ (Figure 5), were analysed for human ␤-globin transgene expression by an S1-nuclease protection assay. Results were quantified by PhosphorImager. (a) Lanes 1 and 2: K562 cells simultaneously probed for ␤-globin transgene (5Ј␤) and endogenous ␥-globin gene (5Ј␥) expression (see Figure 2). Lane Ck, untransfected K562 cells as a negative control. Lanes 3 and 4, MEL cell-derived samples before (Ϫ) and after (+) induced
We also assessed the retention and stability of expression of the cos203␤ construct by culturing a representative pool of stably transfected K562 ( Figure 5 , lane 1) and MEL ( Figure 5 , lane 3) cells in the presence and absence of drug selective pressure for a period of 60 days corresponding to at least 60 generations. Similar pulsedfield gel and Southern blot analysis to that shown in Figure 5 showed that cos203␤ episomes were retained at between two and three copies in K562, but not in MEL cells without any detectable transgene integration events (data not shown). RNA analysis from this pool of K562 cells showed that even in the absence of drug-selective pressure, expression of cos203␤ as a percentage of the endogenous ␥-globin on a episome copy basis, was maintained at a similar level (18-26%) over the 60-day period of culture to the day 0 starting value (22%; Figure 6d ).
Discussion
REVs based on viral origins of replication are showing increasing promise for use in gene therapy. 1, [3] [4] [5] 27 In addition to improving the efficiency of REV delivery, advances in two areas need to be made in order for the utility of this system to be realised: episome maintenance and regulated gene expression. The majority of studies addressing gene expression from within REVs, have focused on the use of ubiquitously acting classical promoter-enhancer combinations, such as those from RSV 28 and CMV. 8 The question of how to obtain efficient tissuespecific expression has not been thoroughly addressed. Inducible systems including the heavy metal responsive human metallothionein II A promoter, 28 the ionophorestimulated rat GRP78 promoters 28 and the incorporation of the dioxin response element 7 have also been tested with varying degrees of success. In this report we address the problem of obtaining strict tissue-specific, long-term gene expression from within REVs. We demonstrate that the DNaseI HS sites that constitute the ␤-globin locus control region (␤LCR) are able to confer cell-type specific gene expression from within REVs. HS sites 2, 3 and 4 act synergistically to give an approximately 95-fold increase in expression compared with the human ␤-globin gene alone and the level of which corresponded to greater than 13% of endogenous ␥-globin mRNA per episome copy (Figure 2b ). In contrast these elements are inactive in promoting enhanced transcription in nonerythroid HeLa cells (Figure 2c) . Generally, the performance of individual and combinations of ␤LCR HS sites in REVs reflects that seen in stably transfected tissue culture cells, [29] [30] [31] [32] rather than transient transfection assays. [33] [34] [35] This difference in the activity of ␤LCR elements when assayed by transient transfection or within REVs, may be due to the fact that REVs adopt a well-ordered, nucleosomal configuration akin to that of native chromatin. 14, 15 Since most (HS1, 3 and 4) ␤LCR elements enhance transcription only when integrated within the host cell genome, the chromatin configuration adopted by REVs would appear to provide the necessary environment for their function. In support of this idea is the report that HS2 can remodel chromatin on REVs 36 in K562 cells, although this study addressed neither tissue-specificity, the cumulative effect of combining ␤LCR HS sites nor the maintenance of the open remodelled chromatin state upon prolonged periods of culture. Importantly in this regard, our own findings show that a ␤LCR HS 234 site Gene Therapy combination, but not HS 3 alone, retain a DNaseI-sensitive structure (Figure 4 ) and gene expression (Figure 3 ) over prolonged periods of time, suggesting that multiple LCR elements are required to maintain a transcriptionally competent open chromatin configuration.
Our data also show that the constructs containing small variants of ␤LCR elements do not contribute to the maintenance of episomes as they are lost from cells cultured in the absence of drug-selective pressure ( Figure  3a ; data not shown). EBV-based vectors disappear from dividing cells over a period of approximately 2 months without selection. 37, 38 Our results showing the episomal loss in K562 cells within 1 to 2 months are, therefore, consistent with previous studies. However, in marked contrast to the small plasmid-based constructs (Figure 1a) , the cos203␤ 38 kb minilocus-REV cosmid vector, was efficiently retained in K562 cells over 60 days of culture in the absence of drug-selective pressure (Figure 6d ; data not shown). Other vector systems with improved persistence inside cells have been reported. An SV40-based episomal vector carrying a scaffold/matrix attachment region (S/MAR) from the human interferon ␤-gene was shown to be able to replicate and maintain in CHO cells over more than 100 generations without selective pressure. 39 The mechanism by which the cos203␤ cosmid construct is retained is currently unknown. However, our findings are consistent with previous observations that found plasmid EBV-based vectors containing randomly selected large (у16 kb) human genomic DNA fragments, conferred efficient episomal replication in mammalian cells. 11, 40 This may involve the presence of either additional genomic origins of replication, 11, 12, 40 or S/MAR elements 39 or both. While the retention of episomes within cells is clearly important, our work indicates that the maintenance of tissue-specific transgene expression from within REVs is also a crucial consideration. Expression of the ␤-globin gene from REVs with either ␤LCR HS2 or HS3 alone significantly declines over time in the presence or absence of drug selective pressure (Figure 3a) . The silencing of ␤-globin gene expression in the presence of drug selection is intriguing as it implies that regions of the same episome can be repressed while others (the hygromycin resistance gene in this case), can remain active. Importantly, our findings imply that as in the case of integrated transgenes, 41 expression from within REVs is prone to silencing but that the inclusion of the ␤LCR prevented this repression of gene function. Therefore, inclusion of elements to counteract the cell's selective gene silencing mechanism will be necessary for the use of episomal constructs in gene therapy. Our data show that combinations of LCR elements can efficiently fulfil this requirement. In this study, we have shown that the cos203␤ minilocus cosmid vector is not only efficiently retained in stably transfected tissue culture cells, but that a significant level of ␤-globin expression (18-26% of ␥-globin per episome copy), was maintained throughout the culture period (Figure 6d ). Although MEL and K562 cells have been used extensively as model systems to study globin gene expression and gene therapy, 20 future developments in technology that will allow the transfer of the large cos203␤ cosmid construct into haematopoietic stem cells are required to extend our observations in a more clinically relevant context. Nevertheless, our results indicate for the first time the feasibility of using REVs for gene therapy of ␤-thalassaemia and sickle cell disease since levels of ␤-globin gene expression that would be therapeutic in such cases can be obtained with as few as 1-2 copies of cos203␤.
Materials and methods
Cells and cell culture K562, 22 MEL 42 and HeLa cells were maintained in DMEM (Life Technologies, Paisley, UK) containing 10% foetal calf serum, 2 mM L-glutamine, 50 g/ml penicillin and 50 units/ml streptomycin. Cells were cultured at 37°C in 5% CO 2 . Transfection of plasmid p220.2-based constructs in K562 and HeLa cells was performed by electroporation using a BioRad Gene Pulser (BioRad, Hertfordshire, UK) at a setting of 0.25 kV and 960 F, with 20-50 g of supercoiled DNA. Transfection of the cos203␤ cosmid ␤-globin minilocus construct into K562 and MEL cells was by lipofection using Lipofectin (Life Technologies) or FuGene6 (Roche, Lewes, UK) according to the manufacturers' instructions. Stably transfected cells were selected in the presence of 250 g/ml hygromycin B. K562 cells harbouring stably integrated transgenes were generated by linearising gene constructs at the unique PvuI site (within the ampicillin resistance gene on the vector) before electroporation. In general, stable pools were analysed 3-4 weeks after transfection, except for long-term culture experiments when approximately 1 × 10 7 cells were divided into media with or without hygromycin and grown for up to a further 60 days.
Replicating episomal constructs
A human ␤-globin gene extending from a 5Ј HpaI site at Ϫ815 bp to an EcoRV site 1685 bp downstream of the poly(A)-addition site in the plasmid GSE1758 30 was removed as a 4.1-kb EcoRV fragment and inserted into a blunted SalI site in the polylinker of p220.2 (Figure 1a) , an Epstein-Barr virus-based vector containing oriP, EBNA-1 and hygromycin resistance genes. 6 This cloning step brings a number of extra restriction sites (including a unique SalI site) 5Ј to the ␤-globin gene (Figure 1a) . The elements of the ␤LCR were isolated as a 1.5-kb KpnI-BglII HS2 fragment, a 1.9-kb HindIII HS3 fragment and a 2.1-kb BamHI-XbaI HS4 fragment. 29 These elements either alone or in combination were inserted by blunt-end ligation into the unique SalI site 5Ј of the ␤-globin gene (Figure 1a) . Constructs which contain more than one HS site were joined, such that their order reflected that found in the native ␤-globin locus on chromosome 11 ( Figure  2a) .
The human ␤LCR minilocus construct 26 was cloned as a 38-kb SalI fragment into the SalI site of the cos203 EBVbased vector which is as p220.2 (Figure 1a ), but includes a cos site for cosmid cloning. This construct was designated as cos203␤.
Isolation of low molecular weight DNA fractions Low molecular weight DNA was prepared by the method of Hirt. 24 Briefly, cells were washed with PBS and subsequently incubated with lysis buffer (0.6% SDS, 10 mM EDTA) for 15 min at room temperature. NaCl was then added to a concentration of 1.4 M. After precipitation overnight at 4°C, genomic DNA and cell debris were pelleted by centrifugation at 10 000 r.p.m. for 10 min in a Beckman J21 high-speed centrifuge. The supernatant was extracted with an equal volume of phenol:chloroform (1:1 v/v) and the DNA precipitated by adding 2.5 volumes of ethanol and storage at Ϫ20°C. The precipitated DNA was collected by centrifugation and resuspended in TE (10 mM Tris-HCl, 1 mM EDTA, pH 7.5) buffer.
Analysis of extrachromosomally replicating episomes
The presence of the REV plasmid constructs (Figures 1  and 2 ) in stably transfected K562 and HeLa cells was assessed as follows. Total DNA (10 g) was prepared as described, 42 digested with BamHI and HindIII and resolved by electrophoresis on a 0.7% agarose gel followed by Southern transfer on to Hybond N+ (Amersham-Pharmacia, Buckingamshire, UK). Blots were then hybridised with 32 P-labeled pBluescript (Stratagene, Amsterdam, The Netherlands), which detects the ampicillin resistance gene on the p220.2 vector backbone. Gel electrophoresis, blotting and hybridisation were carried out using standard procedures. 43 In order to assess the integrity of cos203␤ cosmid episomes in K562 and MEL cells, total genomic DNA (15 g) was digested with SalI, resolved by pulsed field gel electrophoresis employing a BioRad CHEF DRII system (BioRad) and Southern blotted. These blots were then double probed with a 3.6 kb sub-clone of the human ␤-globin gene extending from Ϫ265 to +3400 from the transcriptional start site and the empty cos203 vector backbone. All hybridisation probes were labelled by random priming using a commercially available kit (Amersham-Pharmacia).
Southern blot analysis for episome copy number determination Plasmid, p220.2-based episomal copy number was determined in total genomic DNA (10 g) isolated from K562 and HeLa cells digested with EcoRI and DpnI, resolved by electrophoresis on a 0.7% agarose gels, Southern blotted and probed with a 920-bp BamHI-EcoRI fragment spanning the second intron of the human ␤-globin gene. This probe detects both the endogenous ␤-globin genes as a 5.5-kb fragment and a band of varying size from the different transfected plasmid constructs. The fragment sizes for each construct (see Figure 2a) Total DNA (10 g) from K562 and MEL cells transfected with the cos203␤ cosmid construct, was digested with EcoRI and DpnI and subjected to Southern blot analysis as described above. The samples from K562 cells were hybridised with the BamHI-EcoRI ␤-globin intron II probe alone giving a 4.3-kb cos203␤ derived band. Those from MEL cells were double probed for the endogenous murine vav, which acted as an internal 2 copy gene reference standard. 44 The intensities of bands corresponding to episomal and the endogenous genes were quantified by PhosphorImager and their ratio used to determine episome copy number taking into consideration that K562 cells are trisomy for chromosome 11 22 and therefore possess three copies of the ␤-globin locus.
Quantification of human ␤-globin mRNA Total RNA was extracted from K562, MEL and HeLa cells by selective precipitation in the presence of 3 M LiCl and 6 M urea. 42, 45 Analysis of human ␤-globin transgene expression in these samples was by an S1-nuclease protection assay using 10 g total RNA and end-labelled, double-stranded DNA probes. 25 The 5Ј human ␤-globin probe was a 525-bp AccI cDNA fragment that gives an S1-nuclease protected product of 155 nucleotides. 46 The 5Ј human ␥-globin probe was an 1819-p HindIII-BamHI genomic fragment giving rise to a 205 nucleotide S1-protected product from exon II. The 5Ј murine ␤ maj -globin probe was a 700 bp HindIII-NcoI genomic fragment, which gives a 96 nucleotide S1-protected product. 46 The probe for human hnRNPA2 was prepared as follows: a PCR fragment starting from 330 bp upstream of exon 9 to the 3Ј end of this exon 47 was cloned into the EcoRV site of pBluescript. The probe was prepared by PCR amplification using primers corresponding to a position 545 within pBluescript (5Ј-TGC TGC AAG GCG ATT AA-3Ј) and the 3Ј end of hnRNPA2 exon 9 (5Ј-CTC CTC CAT AGT TGT CAT AAC C-3Ј). This generated a 627-bp probe that results in a 122 nucleotide S1-nuclease protected product. Products were resolved after S1-nuclease digestion on a 6% polyacrylamide gel in the presence of 8 M urea, dried, exposed to Kodak XAR 5 X-ray film and quantified by PhosphorImager (Molecular Dynamics/ Amersham-Pharmacia) analysis.
DNA fluorescence in situ hybridisation (FISH)
DNA FISH was carried out as described 48 with modifications. K562 cells were washed in PBS, resuspended in hypotonic buffer (10 mM HEPES pH7.5, 30 mM glycerol, 1 mM CaCl 2 , 0.8 mM MgCl 2 ) for 10 min. Cells were then washed in methanol/acetic acid (3:1) between three and four times over 30 min. Slides with spread cells were airdried, dehydrated through successive washes in 70%, 90% and 100% ethanol, before treatment with 100 g/ml of RNase A at 37°C for 15 min. The slides were then rinsed in water, dehydrated by successive ethanol washes as before, air-dried and denatured in 70% formamide, 2 × SSC for 2 min at 70°C. The slides were then immediately immersed in ice-cold 70%, 90% and 100% ethanol (3 min each step) and air-dried. The probe used for hybridisation was cos203␤ (see above), which simultaneously detects the endogenous ␤-globin loci and the episomal constructs. DNA (2 g) was labelled with digoxygenin by nick-translation in a 25-l reaction consisting of 0.5 M Tris-HCl pH 7.5, 0.1 M MgSO 4 , 1 mM dithiothreitol, 500 g/ml bovine serum albumin, 0.5 mM dNTPs (dATP, dCTP, dGTP), 0.7 nM digoxygenin-11-dUTP, 5 units DNA polymerase (Roche) and 0.004 units DNaseI (Sigma, Poole, UK) for 40 min at 15°C. Digoxygenin-labelled probes were dissolved in hybridisation mix (50% formamide, 2 × SSC, 200 ng/l of salmon sperm DNA, 5 × Denhardt's solution, 1 mM EDTA, 50 mM sodium phosphate pH 7.0). Probe (20-50 ng) was denatured at 75°C for 5 min in 40 l of hybridisation mix and allowed to anneal at 37°C with 20-fold excess of human Cot-1 DNA for 30 min before applying to the dried and denatured slides. Hybridisation was performed overnight. Slide washes and probe detection were carried out as described. 48 General DNaseI sensitivity analysis Nuclei were prepared from a minimum of 1 × 10 8 K562 cells as described previously 49 using 20 strokes of a Btype Dounce homogenizer. The nuclei were resuspended Gene Therapy in 1 ml of 1 × reticulocyte standard buffer (10 mM TrisHCl pH 7.5, 1 mM NaCl, 3 mM MgCl 2 ) and CaCl 2 was added to a final concentration of 1 mM. Aliquots of 100 l were digested with increasing amounts (0-0.26 g) DNaseI (Sigma) for 2 min at 37°C. The DNaseI digestion was stopped by addition of a stop solution (0.3 M NaCl, 10 mM Tris-HCl, pH 8, 5 mM EDTA, 0.5% SDS final concentrations), made 0.5 g/l proteinase K and incubated overnight at 37°C. Genomic DNA was then extracted using a standard phenol:chloroform and ethanol precipitation procedure. The DNA was resuspended in 100 l of water, 20 l aliquots digested with XbaI restriction enzyme and subjected to Southern blot analysis using a 920-bp BamHI-EcoRI fragment spanning the second intron of the human ␤-globin gene as a hybridisation probe. This gives internal fragments extending over the human ␤-globin gene and part of the ␤LCR elements of 4.5 kb and 6 kb from the 432␤ and 3␤ episomal plasmid constructs, respectively. In addition, an 11 kb band corresponding to the endogenous ␤-globin gene is also obtained, which acts as a reference. The intensity of the hybridised bands was quantified by PhosphorImager. DNaseI digests were performed with nuclei from at least two, independently generated transfected pools of K562 cells for each construct analysed. Since there may also have occurred a slight change in REV copy number within a given pool of cells before and after 30 days of culture, the ratio of the endogenous to episomal ␤-globin bands at each concentration of DNaseI was further compared with that of the no-DNaseI control. This new ratio obtained by dividing the value of the undigested control by each subsequent point within the same DNaseI digestion series, reflects the trend of DNaseI sensitivity for that sample of nuclei allowing comparisons between different cultures.
